Morgan Stanley, CVS Health And More On CNBC's 'Final Trades'
Portfolio Pulse from Lisa Levin
On CNBC's 'Halftime Report Final Trades,' experts shared their picks including U.S. 1 Year Treasury Bill, CVS Health Corporation, Morgan Stanley, and Invesco Food & Beverage ETF. CVS Health reported a 10.6% increase in Q3 sales, beating estimates, and is set for Investor Day on Dec. 5, 2023. Morgan Stanley appointed a new CEO effective Jan. 1. CVS Health, Morgan Stanley, and Invesco Food & Beverage ETF all saw positive price action on Monday.
December 05, 2023 | 2:25 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
CVS Health Corporation reported a 10.6% increase in Q3 sales, surpassing estimates, and is preparing for its Investor Day on Dec. 5, 2023. The stock closed at $68.48 on Monday.
The positive earnings report and upcoming Investor Day are likely to generate investor optimism, potentially leading to a short-term increase in stock price.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Morgan Stanley appointed Edward (Ted) Pick as CEO effective Jan. 1, and the stock gained 0.4% to $81.21 on Monday. Sarat Sethi named it as his final trade amid a pickup in market activity.
The CEO appointment and positive market activity could contribute to a favorable outlook for Morgan Stanley, potentially boosting the stock in the short term.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
NEUTRAL IMPACT
Liz Young of BNY Mellon Investment Management selected Invesco Food & Beverage ETF, which gained 0.7% during Monday's session.
While the ETF experienced a positive gain, the impact of the recommendation on the short-term price is uncertain without more specific catalysts.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 70